Information for Patients and Caregivers
TOBI (Tobramycin Inhalation Solution, USP) is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa. TOBI hasn't been studied in patients under 6 years of age, in those with a lung function outside of a certain range, or in those whose lungs contain other bacteria. Talk to your doctor about the type of patient that should take TOBI.
IMPORTANT SAFETY INFORMATION
If you are allergic to antibiotics in the same family as TOBI (ie, aminoglycosides), you shouldn’t take TOBI. Tell your doctor before starting treatment if you have any history of kidney, hearing, balance or muscle problems.
Patients taking TOBI may have side effects like coughing or temporary difficulty in breathing. Some people taking TOBI experienced ringing in the ears, hearing loss or changes in voice (hoarseness)
.
Ringing in the ears may be a warning sign for hearing loss. If you have ringing in the ears, changes in hearing, or dizziness, you should tell your doctor.
In studies, kidney damage was not seen in patients taking TOBI. However, antibiotics in the same family as TOBI have been linked to kidney damage.
Patients with cystic fibrosis can have many symptoms. Some of these may be related to your medications. You should tell your doctor if you have new or worsening symptoms.
If you are pregnant, plan to become pregnant, or if you are breast-feeding, talk with your doctor before taking TOBI.
